drugset / Trial / NCT00385970
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Phase 3
Unknown
380 enrolled
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy of tegafur/uracil (UFT) plus folinate calcium (leucovorin: LV) administered orally and UFT plus Krestin (PSK) administered orally enrolling patients with pTNM stage IIB or III colorectal cancer as subjects in a multicenter collaborative randomized open-label comparative controlled study and consequently to determine the usefulness of the above regimens as adjuvant therapy after surgery.
Timeline
- Start
- 2006-03
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Krestin | Unknown | 3 g | Oral |
| Comparator | Leucovorin | Small molecule | 75 mg | Oral |
| Background | tegafur-uracil | Small molecule | 300 mg/m2 | Oral |